Live attenuated vaccines mimic natural infections, providing strong immunity but require refrigeration and caution for immunocompromised individuals. Subunit vaccines offer targeted immunity without ...
Peer-Reviewed Article Describes Clinical and Immunologic Rationale for Dual-Antigen MVA-Based Vaccine Designed to Address Limitations of First-Generation COVID-19 Vaccines in Highly Vulnerable ...
Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a leading cause of cirrhosis and liver cancer. While antiviral drugs ...
Verywell Health on MSN
Could a universal flu vaccine replace annual flu and COVID shots?
Fact checked by Jennifer Klump For years, researchers have sought to develop a vaccine that can protect against any current ...
Univercells Technologies agreed to collaborate with Repligen to integrate real-time monitoring capabilities and enhance the development and manufacturing of viral vectors and vaccines. Repligen’s ...
Even before the World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020, the scientific community was mobilizing to develop vaccines with the hope of protecting us all.
A groundbreaking study explains why certain COVID-19 vaccines caused dangerous blood clots, hemorrhages and VITT syndrome, resulting in the deaths of around 200 people in Europe.
DengiAll, which is Panacea Biotec's tetravalent live-attenuated vaccine, uses weakened strains of all four DENV serotypes. As a single-dose shot, it simplifies administration compared to other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results